(111In)Indium Oxinate Labeled Cells

What is (111In)Indium Oxinate Labeled Cells?

Indium-111 labeled cells refer to a specialized diagnostic agent used in nuclear medicine for various imaging purposes, primarily to locate sites of inflammation and infection within the body. This unique preparation involves taking a sample of a patient's own cells, typically white blood cells (leukocytes), and labeling them with a radioactive isotope, Indium-111 (¹¹¹In), in the form of Indium oxinate. The Indium oxinate acts as a chelating agent, allowing the Indium-111 to enter and bind within the cells.

Once these radiolabeled cells are re-introduced into the patient's bloodstream, they behave much like normal cells. White blood cells, in particular, are known for their ability to migrate to areas of inflammation or infection as part of the body's immune response. By tracking these labeled cells using a gamma camera, medical professionals can precisely pinpoint the location of these pathological processes, providing crucial information for diagnosis and treatment planning.

This method is a powerful tool in diagnostic imaging, offering insights that might not be available through other imaging modalities. It is considered a radiopharmaceutical because it combines a radioactive substance with a biologically active component (the cells) for medical use, specifically for diagnostic purposes rather than therapy.

How Does it Work?

The mechanism behind Indium-111 labeled cells is elegantly simple yet highly effective. The process begins with drawing a blood sample from the patient. From this sample, specific cells – most commonly leukocytes (white blood cells) – are isolated. These isolated cells are then incubated with Indium-111 oxinate.

Indium oxinate is a lipophilic (fat-soluble) complex. This property allows it to readily diffuse across the cell membrane and enter the cytoplasm. Once inside the cell, the oxinate ligand dissociates, and the Indium-111 ion binds to various intracellular components, such as proteins and nucleic acids, effectively trapping the radionuclide within the cell. This binding ensures that the Indium-111 remains inside the cell and does not readily leach out after re-injection.

Following successful labeling, the cells are washed to remove any unbound Indium-111 and then re-injected intravenously back into the patient. Because white blood cells naturally migrate to areas of inflammation or infection, the labeled cells will accumulate at these sites. The Indium-111 isotope emits gamma rays, which can be detected externally by a specialized camera called a gamma camera. By capturing these emissions, a nuclear medicine physician can create images that show the distribution and accumulation of the labeled cells, thereby localizing areas of disease.

Medical Uses

The primary and most significant medical application of Indium-111 labeled cells, particularly leukocytes, is in the detection and localization of occult (hidden) inflammation and infection. This technique is invaluable in situations where the source of infection or inflammation is not clear from clinical symptoms or other imaging tests.

• Detection of Occult Infections: This includes identifying the source of fever of unknown origin (FUO), localizing abscesses, and diagnosing infections in orthopedic prostheses (e.g., infected joint replacements).
• Osteomyelitis: It is highly effective in diagnosing osteomyelitis (bone infection), especially in cases where conventional X-rays or MRI might be inconclusive, or in diabetic foot infections.
• Inflammatory Bowel Disease (IBD): Labeled leukocytes can accumulate in inflamed bowel segments, helping to assess the extent and activity of conditions like Crohn's disease and ulcerative colitis.
• Vascular Graft Infections: Identifying infections in vascular grafts or other implanted medical devices.
• Monitoring Immune Response: In some specialized research settings, Indium-111 labeled cells can be used for general cell tracking to study the kinetics and distribution of specific cell types, though this is less common in routine clinical practice.

The high specificity of labeled leukocytes for active inflammatory and infectious processes makes this imaging modality a crucial diagnostic tool in complex clinical scenarios.

Dosage

The administration of Indium-111 labeled cells differs significantly from standard oral or injectable medications. It is not a fixed-dose drug but rather a personalized diagnostic procedure involving the patient's own cells. The 'dosage' refers to the amount of radioactivity administered, measured in Megabecquerels (MBq).

Typically, an adult patient will receive an intravenous injection of 10-20 MBq of Indium-111 incorporated into their own leukocytes. The exact activity can vary based on the specific indication, the patient's body weight, and the protocols of the nuclear medicine department. For pediatric patients, the dose is adjusted based on body weight or surface area to minimize radiation exposure.

The preparation process is meticulous: first, a blood sample (usually 40-60 ml) is drawn from the patient. The white blood cells are then isolated from the blood, a process that can take several hours. These isolated cells are then incubated with the Indium-111 oxinate to allow for labeling. After labeling, the cells are washed and resuspended in a sterile saline solution for re-injection. Imaging usually commences 4 to 24 hours after the re-injection, allowing sufficient time for the labeled cells to migrate to target sites.

Side Effects

Indium-111 labeled cells are generally well-tolerated, as the procedure primarily involves the re-injection of the patient's own cells. However, as with any medical procedure involving blood handling and injections, certain side effects can occur:

• Injection Site Reactions: Common and usually mild, including pain, bruising, or localized swelling at the site of blood draw or re-injection.
• Allergic Reactions: While rare, allergic reactions to the Indium oxinate complex or other components used in the labeling process are possible. Symptoms could include rash, itching, or, in very rare cases, more severe anaphylactic reactions.
• Transient Fever or Chills: Some patients may experience a mild, transient fever or chills following the re-injection of labeled cells. This is thought to be due to the re-infusion of processed cells rather than the radiopharmaceutical itself.
• Radiation Exposure: As a radiopharmaceutical, there is exposure to ionizing radiation. However, the dose is carefully controlled to be as low as reasonably achievable (ALARA principle) for diagnostic purposes. The risks associated with this low level of radiation are generally considered minimal and are far outweighed by the diagnostic benefits, especially when investigating serious conditions like occult infections.
• Technical Issues: Rarely, issues during the cell labeling process, such as inadequate cell viability or clumping of cells, could potentially lead to suboptimal image quality or unexpected cell distribution.

Patients should always discuss any concerns about potential side effects with their healthcare provider.

Drug Interactions

Unlike many pharmaceuticals, Indium-111 labeled cells do not typically engage in systemic drug-drug interactions in the conventional sense, as it is a diagnostic agent composed of the patient's own cells labeled with a radionuclide. The primary 'interaction' considerations revolve around factors that might influence the function or distribution of the labeled cells, particularly white blood cells.

• Immunosuppressants and Corticosteroids: Medications that suppress the immune system, such as high-dose corticosteroids or chemotherapy agents, can reduce the number and migratory capacity of white blood cells. This could potentially diminish the accumulation of labeled cells at sites of inflammation or infection, leading to false-negative results or reduced sensitivity of the scan.
• Antibiotics: If a patient is already on effective antibiotic therapy, the bacterial load at an infection site might be reduced. This could decrease the inflammatory response and subsequent migration of labeled leukocytes, potentially impacting the diagnostic accuracy. It's often preferred to perform the scan before initiating antibiotics or during a 'washout' period if clinically feasible.
• Recent Blood Transfusions or Chemotherapy: These can affect the quantity and quality of circulating leukocytes, which might impact the success of cell isolation and labeling, as well as the overall interpretation of the scan.
• Other Radiopharmaceuticals: While unlikely to be administered concurrently with Indium-111 labeled cells, the presence of other radiopharmaceuticals in the body could theoretically interfere with imaging if their emission energies overlap with Indium-111, leading to background noise or misinterpretation.

It is crucial for patients to inform their healthcare team about all medications they are taking, including over-the-counter drugs and supplements, to ensure optimal diagnostic outcomes and accurate interpretation of the scan results.

FAQ

Q: Is the procedure for Indium-111 labeled cells painful?

A: The procedure involves a standard blood draw and an intravenous injection, similar to a routine blood test. You might feel a brief pinch or sting, but it is generally well-tolerated. The cell labeling process itself occurs outside the body and is not painful.

Q: How long does the entire process take?

A: The blood draw and re-injection are relatively quick. However, the cell isolation and labeling process in the lab can take several hours (typically 2-4 hours). After re-injection, imaging is usually performed 4 to 24 hours later, and sometimes delayed images at 48 hours are taken. So, the entire diagnostic process spans a day or two.

Q: What should I do to prepare for the scan?

A: Specific preparation instructions will be provided by your healthcare team. Generally, no special fasting is required. You should inform your doctor about any medications you are taking, especially antibiotics or corticosteroids, as these might affect the scan results.

Q: Is Indium-111 labeled cells safe during pregnancy or breastfeeding?

A: Due to the radiation exposure, this procedure is generally contraindicated during pregnancy unless the potential benefits significantly outweigh the risks to the fetus, and no alternative diagnostic methods are available. For breastfeeding mothers, temporary cessation of breastfeeding may be recommended after the procedure, with specific guidance from your nuclear medicine physician.

Q: What is the difference between Indium-111 labeled WBCs and a Gallium-67 scan?

A: Both are nuclear medicine scans used to detect infection and inflammation. However, Indium-111 labeled cells, particularly white blood cells (WBCs), are generally more specific for acute pyogenic (pus-forming) bacterial infections. Gallium-67 is a broader agent that accumulates in various inflammatory processes, some tumors, and certain chronic infections, making it less specific for acute bacterial infections but useful in other contexts.

Products containing (111In)Indium Oxinate Labeled Cells are available through trusted online pharmacies. You can browse (111In)Indium Oxinate Labeled Cells-based medications at ShipperVIP or Medicenter.

Summary

Indium-111 labeled cells represent a powerful and highly specific diagnostic tool within the field of nuclear medicine. By utilizing the body's own cells, typically leukocytes, and tagging them with the Indium-111 radionuclide, this radiopharmaceutical allows for precise cell tracking to identify and localize areas of active inflammation and infection. This capability is invaluable for diagnosing conditions such as occult abscesses, osteomyelitis, and inflammatory bowel disease, especially when other imaging modalities are inconclusive.

The procedure involves isolating and labeling the patient's cells ex-vivo, followed by re-injection and subsequent gamma camera imaging. While involving a small dose of radiation, the diagnostic benefits often far outweigh the minimal risks, providing critical information for effective patient management. Understanding its mechanism, medical uses, and potential considerations regarding dosage and drug interactions is key to leveraging this advanced diagnostic imaging technique for improved patient care.